Investing.com -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) stock surged 22% after the company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its ...

Wedbush maintained its Outperform rating on Palantir Technologies (NASDAQ:PLTR) and raised the price target on the stock to $160 from $140, citing confidence in the company's AI strategy, as the ...

Dan Ives has raised his price target for Palantir Technologies, signaling a 12% upside from its trading price over the next ...

A core AI holding Palantir Technologies (NASDAQ: PLTR) posted 39% year-over-year revenue growth in Q1 2025 to $884 million. U ...